RK

Rupa Kumari

Active Director Director DIN 10186666
DIN 10186666 First appointment Jun 2023 Primary industry Research & Development
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value •••• Premium profile

About Rupa Kumari

Data last updated:

Rupa Kumari is a Director at Novencia Pharmaceuticals Private Limited (since 2023). The company operates in Research & Development. Novencia Pharmaceuticals Private Limited reported revenue of ₹1.4 Lakh (FY 2024).

DIN 10186666
Primary Designation Director
Industry Research & Development
First Appointment 01 Jun 2023
Oldest Company Age 3 yrs
Largest company Novencia Pharmaceuticals Private Limited · ₹1.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Jun 20232023₹1.4 Lakh (FY 2024)Active

Board colleagues of Rupa Kumari

NameDINCompanyDesignation
Runa Mishra10186665Novencia Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Novencia Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rupa Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rupa Kumari

Rupa Kumari currently holds 1 directorship: Novencia Pharmaceuticals Private Limited (Director, since 01 Jun 2023, revenue ₹1.4 Lakh (FY 2024)).

Rupa Kumari was first appointed on 01 Jun 2023 as Director at Novencia Pharmaceuticals Private Limited.

The current boards of Rupa Kumari's companies include Runa Mishra (Novencia Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available